Rise4

Rise4 is a specialized marketing and operations agency serving TMS, Ketamine, and Spravato® clinics across the United States. The company operates from a unique position as clinic operators themselves, having built 13 successful mental health clinics before launching their agency services. They provide end-to-end solutions spanning patient acquisition, intake management, treatment enrollment, and practice launch consulting.

The agency's service model combines digital marketing with operational support, including a proprietary HIPAA-compliant CRM system, trained intake coordinators, and staffing solutions. Their approach focuses on the complete patient journey from initial lead generation through treatment scheduling and insurance verification. Rise4 has established preferred partner relationships with major TMS equipment manufacturers including Brainsway, Apollo TMS, and Magstim, as well as Johnson & Johnson for Spravato services.

Published case studies document measurable outcomes for client clinics, including a 23x return on investment in some instances. One client, TMS of Austin, generated 94 leads and administered 73 treatments from a $95,000 investment, while Evolve Brain Health scaled from $1,700 to over $91,000 in monthly revenue. The company maintains active relationships with approximately 10-15 named mental health clinics nationwide.

Clinics should consider Rise4 when they need more than advertising services and require operational support to convert leads into enrolled patients. The agency's background as clinic operators means they understand the full patient journey from initial inquiry through treatment start, including the insurance verification and scheduling challenges specific to interventional psychiatry.

Expect a partnership that extends beyond typical agency relationships, with potential involvement in intake processes, staff training, and operational workflow design. Their specialized focus means they bring treatment-specific knowledge about TMS, ketamine, and Spravato patient education and enrollment that generalist healthcare marketers may lack.

Rise4 maintains exclusive focus on the interventional psychiatry sector, specifically serving clinics offering TMS (Transcranial Magnetic Stimulation), ketamine infusion, and Spravato (esketamine) treatments for depression and other mental health conditions. Their healthcare specialization extends beyond marketing to include HIPAA-compliant data systems, insurance verification processes, and clinical intake workflows specific to these treatment modalities.

The company has established formal partnership relationships with medical device manufacturers in the TMS space and pharmaceutical companies in the esketamine category, positioning them as endorsed growth partners within the interventional psychiatry industry. Their services address the unique regulatory and compliance requirements of behavioral health practices, including HIPAA, FCC, and CMS regulations specific to patient communications and data handling.

The ideal Rise4 client is a TMS, ketamine, or Spravato clinic seeking holistic growth support that encompasses both patient acquisition and operational efficiency. Practices launching new treatment programs, scaling existing services, or struggling with lead-to-patient conversion rates will benefit from their combined marketing and intake management approach. Clinics comfortable with outsourcing aspects of patient enrollment and willing to adopt their HIPAA-compliant CRM system will realize the most value.